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tion to coronary bypass surgery 14 years earlier, at least eight
PTCAs had been performed. Most of these involved stent place-
ment and were also performed via the right femoral artery,
including the most recent PTCA that had been done only 4 days
before the carotid PTA.
Vancomycin therapy was instituted immediately after blood
cultures had been drawn on the night that the fever began. A
duplex ultrasound scan of the right groin that was performed the
next morning failed to reveal a pseudoaneurysm or even a
hematoma. Blood cultures demonstrated the presence of gram-
positive cocci that subsequently were identified as methicillin-
susceptible Staphylococcus aureus (MSSA). A 2-dimensional echo-
cardiogram was interpreted to show trace aortic insufficiency,
together with the possibility of a mobile echodensity involving
the aortic valve.
Because of persistent MSSA bacteremia with spiking fevers,
gentamicin was added to the antibiotic regimen on the following
day. The patient developed Janeway microembolic lesions1 on the
toes and the sole of the right foot (Fig 1). Including the initial set,
8 of the 12 blood cultures that were obtained during the first week
of illness grew MSSA. The duplex study and the echocardiogram
were repeated 5 days after the fever had begun. Neither revealed a
clear source for the infection, and the mobile aortic valve echoden-
sity was no longer seen. However, the groin, which initially had
improved, became more painful, and scanty purulent drainage
developed. Two days later, a third duplex study appeared to demon-
strate a pseudoaneurysm of the right common femoral artery.
The groin was explored later that same day, at which time an
infected intramural hematoma penetrating into an ulcerated ath-
erosclerotic plaque was found at the previous femoral artery can-
nulation site (Fig 2). A typical pseudoaneurysm was not present.
Given uncertainty regarding the anatomic extent of infection and
the presence of an adjacent thick plaque, it was deemed appropri-
ate to replace the entire segment of involved artery. This segment
of the common femoral artery was completely resected and
replaced with a reversed saphenous vein graft (harvested from the
ipsilateral thigh) to the deep femoral artery, with end-to-side
implantation of the superficial femoral artery into the new auto-
genous graft and coverage of the reconstruction with a sartorius
Ever since the introduction of percutaneous translumi-
nal coronary angioplasty (PTCA) in 1977, catheter-based
coronary procedures have allowed millions of patients to
avoid open surgical operations. However, despite their suc-
cess, these procedures are sometimes associated with com-
plications leading to additional morbidity of their own.
Although experience with an expanding array of new
catheter interventions has been relatively limited in com-
parison with PTCA, the incidence and clinical presentation
of complications related to their arterial access will proba-
bly be similar to those that already have been reported for
coronary patients. We recently encountered an unusual
problem of this kind after carotid percutaneous translumi-
nal angioplasty (PTA) and intraluminal stenting.
CASE REPORT
Spiking fevers to 40°C developed in a 67-year-old white man,
associated with diaphoresis, rigors, and transient hypotension. His
symptoms began approximately 48 hours after carotid angiogra-
phy with PTA and stent deployment in the right carotid artery.
His examination at the time the fever began revealed a grade-2
holosystolic cardiac murmur consistent with mitral regurgitation,
which was thought to be present before his catheterization pro-
cedures. He also had a tender, nonpulsatile mass in the right groin
at the femoral artery cannulation site. His medical history was
remarkable for severe coronary artery disease for which, in addi-
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Arterial infection and Staphylococcus aureus
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In this report, we present a patient who developed an infected femoral artery after repuncture cannulation for carotid
angioplasty and intraluminal stenting. The case was complicated by persistent bacteremia and a delay in diagnosis
before it was managed successfully with an autogenous replacement graft and appropriate antibiotics. Overt stent infec-
tion is exceedingly rare, but according to the literature describing transfemoral coronary artery intervention, the spec-
trum of clinical syndromes related to infection of the arterial puncture site includes local invasion, pseudoaneurysm
formation, septic embolization to the distal limb, and bacteremia. The diagnosis requires a high degree of clinical sus-
picion and is often delayed. Although the incidence of infectious complications reported for percutaneous intra-arter-
ial interventions historically has been low, the absolute number of these complications almost certainly will increase in
the future because of the expanding array of interventional procedures that is becoming available. (J Vasc Surg
2002;35:576-9.)
muscle flap. The deep subcutaneous layer was closed over the sar-
torius muscle, but the remainder of the incision was left open,
managed with moist saline dressings, and healed by secondary
intention approximately 3 weeks later. Cultures of the excised
arterial specimen also grew MSSA. The febrile illness and bac-
teremia promptly resolved, and the patient has fully recovered
from his infection. Given the high-grade nature of the bacteremia
and concern surrounding the recently implanted stents, he was
treated with 8 weeks of parenteral antistaphyloccocal penicillin
therapy and thereafter with lifelong suppressive oral cephalexin.
After 24 months of follow-up, there has been no recurrence of his
local complications or any evidence of infection involving either
of his most recent intravascular stents.
DISCUSSION
Infectious complications of diagnostic cardiac
catheterization and PTCA are rare events, with an inci-
dence of less than 1%.2-6 Even though early investigators
postulated that PTCA would be associated with higher
rates of infection because of prolonged arterial cannula-
tion and frequent catheter manipulations in comparison
with diagnostic catheterization, the incidence of related
bacteremia remains low. Shea et al7 prospectively studied
164 transfemoral PTCA procedures and reported an 8%
incidence of catheter colonization, but only one case
(0.6%) of documented bacteremia. Frazee and Flaherty8
predicted that use of the brachial artery for catheterization
might be associated with higher rates of bacteremia
because this approach usually requires open exposure, but
this has not been investigated prospectively.
In a retrospective series of 4217 PTCAs, Samore et al5
also found a 0.6% incidence of related bacteremia. Of the
27 cases of bacteremia, 14 involved S. aureus, and 9 were
associated with coagulase-negative staphylococci; other
organisms included enterococcus, group B streptococci,
and Escherichia coli. Local infectious complications
occurred in 10 of the 27 bacteremic patients, including
infected femoral artery aneurysms (3), groin abscesses (3),
septic femoral artery thrombosis (2), and ipsilateral septic
arthritis (2). Nine of the 10 local complications were
caused by S. aureus. Several authors have described
femoral artery endarteritis that sometimes has been associ-
ated with infected aneurysms or pseudoaneurysms, all but
one of these cases being secondary to S. aureus.8-12 Frazee
and Flaherty8 defined endarteritis as “formation of a
pseudoaneurysm found to be purulent upon surgical
exploration, evidence of regional septic emboli, or persis-
tently positive blood cultures in the absence of endocardi-
tis.” Other reported complications of PTCA have included
pseudomonal cardiac abscess,13 staphylococcal endocardi-
tis,14 extremity osteomyelitis,8,15 and endophthalmitis.16
According to the multivariate regression analysis con-
ducted by Samore et al,5 risk factors for infectious compli-
cations included congestive heart failure (odds ratio [OR],
43.3), recannulation of the same site (OR, 4.0), difficulty
obtaining vascular access (OR, 14.9), duration of sheath
retention for more than 1 day (OR, 6.8), and length of the
interventional procedure extending beyond 2 hours (OR,
2.9). Bleeding from the arterial puncture site was not eval-
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uated as a risk factor in this study, but in another prospec-
tive study of 500 patients, McHenry et al14 found that
local bleeding independently conferred risk for infectious
complications. The use of percutaneous hemostatic clo-
sure devices also has been proposed as a risk factor for
infection. In a retrospective series of 108 consecutive pro-
cedures in which such devices were employed, Cooper and
Miller17 found that staphylococcal bacteremia developed
in two patients (1.9%). These authors speculated that the
device served as a nidus for further compromise of host
endovascular resistance, but they reported no comparable
data for cases in which hemostatic devices were not used
at their center.
Recently, the array of available stent procedures has
increased, and the indications are still evolving. Carotid
stenting will likely carry the attendant risks of other per-
cutaneous angiographic interventions, including the
potential risk of stent infection. Despite the deployment of
hundreds of thousands of coronary stents annually, there
are only two examples of documented stent infection in
the literature, one caused by Pseudomonas aeruginosa and
the other by S. aureus.18,19 Theoretically, endovascular
stents and the arteries in which they are deployed repre-
sent at least some risk for infection, because PTCA and
stent placement injure the intima and may act as a nidus
for bacterial adherence, thus establishing an environment
for microbial colonization.20 It is unclear why there have
not been more stent infections, but the reason may relate
to flow-directed seeding of the majority of bacteria toward
the periphery. Although there are no case reports of
carotid stent infection, seven cases of S. aureus iliac artery
stent infection have been described, with pseudoaneurysm
formation or septic thrombosis in all but two of them.20
The diagnosis of infectious complications of PTCA
depends on clinical, microbiologic, and radiographic evi-
dence. A delay in establishing the diagnosis is not uncom-
mon. Purulent drainage from the puncture site or signs of
distal embolization obviously suggest infection, but both
duplex ultrasound scanning and computed tomography
may fail to demonstrate infected pseudoaneurysms.10,15
Fig 1. Janeway lesion on the sole of the right foot.
Blood cultures can take up to 20 days to become positive
even for organisms that are easily cultured, such as S.
aureus.5 In one case, an infected aneurysm was not clinically
apparent until 1 month after PTCA.21 Another case defied
diagnosis for nearly 6 months,15 including a negative pelvic
computed tomography scan well into the course of the ill-
ness; similar to the patient described in our own report, this
particular patient also had undergone cerebral angiography,
albeit for the purpose of coil embolization of an intracranial
aneurysm. Under appropriate circumstances, therefore, it is
important to maintain a low threshold for surgical groin
exploration and timely antibiotic therapy.
Arteritis complicating arterial cannulation generally is
precipitated by trauma to the arterial wall with concomi-
tant direct contamination or by seeding from a site of con-
tiguous infection, such as an infected hematoma or
pseudoaneurysm. The incidence of pseudoaneurysm for-
mation after PTCA is 3.5% to 5.5%.22 Atherosclerosis or
endothelial ulceration may reduce resistance to intra-
arterial infection. Previous vascular injury with scar forma-
tion, ongoing inflammation, or low-grade colonization
from recent procedures seem likely to contribute to the
increased risk noted for repuncture cannulation. The
mechanism that might be responsible for the higher risk
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for infection that has been described for patients with con-
gestive heart failure remains unclear.
The patient in our report presumably was at increased
risk both because of recannulation of the ipsilateral femoral
artery and because groin bleeding developed the day after
the procedure. The presence of an ulcerated atherosclerotic
plaque at the arterial puncture site and intimal damage
from multiple historical procedures also may have provided
a nidus for infection. Diagnostic clues included fever, per-
sistently positive blood cultures, purulent local drainage,
and septic emboli to the distal extremity (Janeway lesions).
On the basis of the criteria proposed by Frazee and
Flaherty,8 the embolic stigmata alone were eventually suf-
ficient to establish the diagnosis of endarteritis.
Prevention of infectious complications of PTCA has
not been well studied. Most authors have advised against
routine antimicrobial prophylaxis,7 whereas others have
recommended prophylaxis for ipsilateral repuncture when
contralateral puncture is not feasible.11,23 Prospective
studies have not yet been performed to address the effec-
tiveness and benefit of prophylactic antimicrobials in high-
risk PTCAs. In the presence of significant risk factors,
prophylactic antimicrobial administration directed at skin
flora at the time of the procedure should be considered.
For cases in which endarteritis does occur, accepted surgi-
cal management includes resection of the diseased arterial
segment and antibiotic treatment that is analogous to that
for infectious endocarditis.24-26
CONCLUSIONS
Infectious complications of PTCA occur only rarely,
but those related to arterial access are probably typical of
other catheter-based procedures. Most documented cases
have involved S. aureus. High-risk clinical situations—such
as congestive heart failure, a difficult cannulation, ipsilat-
eral repuncture, prolonged sheath retention, puncture site
bleeding, and a lengthy interventional procedure—should
sensitize clinicians to the possibility of infection to avoid
the delay in diagnosis that can otherwise often occur.
When the index of suspicion is high, early management
with appropriate antibiotics and consideration of surgical
exploration are warranted.
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